Keyphrases
Anal Swab
16%
CagA
16%
Cardiovascular Risk
16%
Colonoscopy
19%
Colorectal Cancer
38%
Colorectal Cancer Patients
51%
Consensus Document
18%
Constipation
22%
Constipation Symptoms
40%
Cyclin D1 (CCND1)
16%
Depressive Symptoms
16%
Diagnostic Biomarker
16%
Dyspepsia
32%
Early-onset Colorectal Cancer (EOCRC)
32%
Epidemiological Study
16%
Functional Constipation
70%
Gastric Cancer
20%
Gastroesophageal Reflux Disease
19%
Gastrointestinal Diseases
18%
Gene-gene Interaction
16%
General Hospital
28%
Genotype
16%
Helicobacter Pylori (H. pylori)
36%
Helicobacter Pylori Infection
51%
Indonesia
100%
Indonesian
32%
Indonesian Language
19%
Indonesian Patients
28%
Inflammation
18%
Jakarta
25%
Late-onset Colorectal Cancer
22%
Non-variceal Upper Gastrointestinal Bleeding
18%
Patient Assessment
29%
Patient Assessment of Constipation Quality of Life
16%
Patient-derived Spheroids
16%
Patients with Colorectal Cancer
19%
Peripheral Blood
19%
Primary Cell Culture
16%
Quality of Life Questionnaire
16%
Quantitative PCR
16%
Questionnaire Reliability
16%
Questionnaire Validity
16%
Randomized Double-blind Controlled Trial
34%
Recombinant Lactobacillus Plantarum
19%
Rheumatoid Arthritis Patients
16%
Risk Factors
22%
Symptom Severity
32%
Tumor Microenvironment
32%
Urban Women
32%
Virulence Genes
16%
Medicine and Dentistry
Abdominal Cancer
22%
Argon Plasma Coagulation
16%
Bleeding
14%
Cell Culture
16%
Circulating Tumor Cell
16%
Colonoscopy
20%
Colorectal Carcinoma
73%
Constipation
57%
COVID-19
16%
COVID-19 Diagnosis
16%
Cyclin D1
16%
Endoscopic Biopsy
16%
Endoscopic Hemostasis
16%
Esophageal Stricture
16%
Fenofibrate
13%
Functional Constipation
67%
Gastroesophageal Reflux
18%
Gastrointestinal Bleeding
20%
Gastrointestinal Cancer
16%
Gastrointestinal Distress
16%
Gastrointestinal Infection
16%
Gene Interaction
16%
Helicobacter Infection
34%
Helicobacter Pylori
54%
Indonesian (Language)
18%
Infection
30%
Lactobacillus plantarum
18%
Lymphocyte
16%
Malignant Neoplasm
24%
Nasopharyngeal Swab
16%
Neoplasm
19%
Non-Invasive Diagnostics
16%
Patient Assessment
41%
Prevalence
51%
Principal Component Analysis
15%
Probiotics
48%
Propofol
16%
Quality of Life
18%
Retrospective Study
16%
Reverse Transcription Polymerase Chain Reaction
16%
Selectin (Glycoprotein)
16%
Short Chain Fatty Acid
16%
Stomach Acid
32%
Stomach Antrum Vascular Ectasia
16%
Supplementation
16%
Survival Rate
16%
Tumor Microenvironment
32%
Tumor Spheroid
16%
Upper Gastrointestinal Bleeding
21%
Urban Population
16%
